Inhibitory effects of higenamine on dopamine content in PC12 cells.
The inhibitory effects of (+/-)-higenamine, a benzylisoquinoline alkaloid, on dopamine biosynthesis in PC12 cells were investigated. Higenamine decreased the intracellular dopamine content dose-dependently and showed 55.2% inhibition of dopamine content in PC12 cells at a concentration of 20 microM with 24 h incubation. The IC50 value of higenamine was 18.2 microM. Dopamine content was lowered and reached minimal level at 12-24 h after exposure to higenamine. In this condition, tyrosine hydroxylase, the rate-limiting enzyme of catecholamine biosynthesis, was also inhibited by the treatment of higenamine in PC12 cells (21.9% inhibition at 20 microM). Higenamine at 20 microM lowered the intracellular Ca2+ concentration by 33.1% inhibition relative to control in PC12 cells. These results suggest that the inhibition of tyrosine hydroxylase activity by higenamine might partially contribute to the decrease in dopamine content in PC12 cells.
J S
JS
Shin
H S
HS
Yun-Choi
E I
EI
Kim
M K
MK
Lee
D000470:Alkaloids / Q000494:pharmacology*; D000818:Animals; D001599:Berberine / Q000494:pharmacology; D002316:Cardiotonic Agents / Q000494:pharmacology*; D004298:Dopamine / Q000494:pharmacology*; D007700:Kinetics; D016716:PC12 Cells; D051381:Rats; D044005:Tetrahydroisoquinolines
D000470:Alkaloids; D002316:Cardiotonic Agents; D044005:Tetrahydroisoquinolines; D001599:Berberine; C012348:higenamine; D004298:Dopamine